Originally published January 21 2004
The FDA now plans to assault herbal medicines
by Mike Adams, the Health Ranger, NaturalNews Editor
Prescription drugs injure 2.2 million Americans each year and manage to
kill well over 100,000. The FDA is charged with the safety of such
drugs, so what does the FDA plan to do now? Assault herbal medicine, of
course. After banning ephedra -- an herb that has been safely use in
China for literally thousands of years and has only been associated with
a handful of deaths in the United States -- the FDA apparently feels
compelled to go after other natural medicines that compete with the
profits of prescription drugs, which the FDA seems determined to
protect. This isn't rational, and it's not science: it's a witch
hunt. There is no set level of risk for a drug or nutritional supplement
that triggers a ban by the FDA. Rather, the FDA simply allows virtually
any drug to stay on the market, regardless of how many patients
it kills (Rezulin, a diabetes drug, reportedly killed 10,000 people and
damaged the livers of 100,000 before the FDA finally pulled it), while
simultaneously applying an entirely different standard to herbal
medicines and nutritional supplements.
This is just one of many
reasons why we seriously need FDA reform. The FDA has forgotten its
mission and betrayed the American public by defending -- in fact,
promoting -- the commercial interests of drug companies alone. And in
doing so, it has put us all at risk.
REVIEW TYPE
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml